255 related articles for article (PubMed ID: 3823822)
1. [Indications for passive immunotherapy in infectious diseases].
Baumgartner JD
Schweiz Med Wochenschr; 1987 Jan; 117(3):84-90. PubMed ID: 3823822
[TBL] [Abstract][Full Text] [Related]
2. [Therapy with immunoglobulins].
Schumacher K
Dtsch Med Wochenschr; 1986 Apr; 111(14):550-6. PubMed ID: 3514195
[No Abstract] [Full Text] [Related]
3. Immunoprophylaxis and immunotherapy of Gram-negative infections in the immunocompromised host.
Glauser MP; McCutchan JA; Ziegler E
Clin Haematol; 1984 Oct; 13(3):549-55. PubMed ID: 6388931
[TBL] [Abstract][Full Text] [Related]
4. [Immunoglobulins and rules of passive-active prophylaxis].
Bucholc B
Przegl Epidemiol; 2003; 57(2):391-7. PubMed ID: 12910611
[TBL] [Abstract][Full Text] [Related]
5. [Clinical use of immunoglobulins].
Nicodemo AC; Amato Neto V
Rev Hosp Clin Fac Med Sao Paulo; 1992; 47(1):46-52. PubMed ID: 1307403
[TBL] [Abstract][Full Text] [Related]
6. [Present concepts concerning therapy with immunoglobulins].
Kondi V; Mitrică N
Microbiol Parazitol Epidemiol (Bucur); 1973; 18(5):401-12. PubMed ID: 4129130
[No Abstract] [Full Text] [Related]
7. Intravenous immunoglobulin for prophylaxis or treatment of bacterial infection in neonates.
Christensen RD
J Perinatol; 1987; 7(1):58-61. PubMed ID: 3333793
[TBL] [Abstract][Full Text] [Related]
8. [New indications for intravenous immunoglobulins].
Lobut JB; Reinert P
Rev Prat; 1990 May; 40(15):1393-5. PubMed ID: 2356430
[No Abstract] [Full Text] [Related]
9. Role of monoclonal antibody therapy in the treatment of infectious disease.
Chmel H
Am J Hosp Pharm; 1990 Nov; 47(11 Suppl 3):S11-5. PubMed ID: 2275476
[TBL] [Abstract][Full Text] [Related]
10. Oral immunotherapy with yolk antibodies to prevent infections in humans and animals.
Larsson A; Carlander D
Ups J Med Sci; 2003; 108(2):129-40. PubMed ID: 14649324
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin therapy in serious infections.
J Hosp Infect; 1988 Aug; 12 Suppl D():1-73. PubMed ID: 2902124
[No Abstract] [Full Text] [Related]
12. [Use of Immunoglobulins].
Franke F
Ther Ggw; 1972 Apr; 111(4):480-2 passim. PubMed ID: 5029713
[No Abstract] [Full Text] [Related]
13. Polyclonal immunoglobulins and hyperimmune globulins in prevention and management of infectious diseases.
Hsu JL; Safdar N
Infect Dis Clin North Am; 2011 Dec; 25(4):773-88. PubMed ID: 22054755
[TBL] [Abstract][Full Text] [Related]
14. [Protective properties of antibodies raised against conjugates of endotoxin core oligosaccharides with proteins].
Jachymek W
Postepy Hig Med Dosw; 1995; 49(1):171-8. PubMed ID: 8657614
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin therapy in older infants and children.
Fischer GW
Infect Dis Clin North Am; 1992 Mar; 6(1):97-116. PubMed ID: 1578124
[TBL] [Abstract][Full Text] [Related]
16. [Intravenous immunoglobulins in the prevention of infection in children with hematologic-oncologic diseases].
Lehrnbecher T
Klin Padiatr; 2001 Sep; 213 Suppl 1():A103-5. PubMed ID: 11577369
[TBL] [Abstract][Full Text] [Related]
17. Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis.
Dunn DL; Mach PA; Condie RM; Cerra FB
Surgery; 1984 Aug; 96(2):440-6. PubMed ID: 6379963
[TBL] [Abstract][Full Text] [Related]
18. Polyclonal intravenous immune globulin for prevention and treatment of infections in critically ill patients.
Cometta A; Baumgartner JD; Glauser MP
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):69-72. PubMed ID: 8033438
[TBL] [Abstract][Full Text] [Related]
19. Controversies in the use of passive immunotherapy for bacterial infections in the critically ill patient.
Baumgartner JD; Glauser MP
Rev Infect Dis; 1987; 9(1):194-205. PubMed ID: 3547572
[TBL] [Abstract][Full Text] [Related]
20. [Immunoglobulins in prohylaxis and therapy].
Hanson LA
Lakartidningen; 1972 Dec; 69():Suppl 4:85-9. PubMed ID: 4632635
[No Abstract] [Full Text] [Related]
[Next] [New Search]
